- Home
- OCC vs TPST Comparison
OCC vs TPST Comparison
Compare OCC & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- TPST
- Stock Information
- Founded
- OCC 1983
- TPST 2011
- Country
- OCC United States
- TPST United States
- Employees
- OCC N/A
- TPST N/A
- Industry
- OCC Telecommunications Equipment
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- TPST Health Care
- Exchange
- OCC Nasdaq
- TPST Nasdaq
- Market Cap
- OCC 40.9M
- TPST 33.0M
- IPO Year
- OCC 1996
- TPST N/A
- Fundamental
- Price
- OCC $5.32
- TPST $10.16
- Analyst Decision
- OCC
- TPST Hold
- Analyst Count
- OCC 0
- TPST 3
- Target Price
- OCC N/A
- TPST $30.00
- AVG Volume (30 Days)
- OCC 74.1K
- TPST 111.5K
- Earning Date
- OCC 09-10-2025
- TPST 08-11-2025
- Dividend Yield
- OCC N/A
- TPST N/A
- EPS Growth
- OCC N/A
- TPST N/A
- EPS
- OCC N/A
- TPST N/A
- Revenue
- OCC $68,999,601.00
- TPST N/A
- Revenue This Year
- OCC N/A
- TPST N/A
- Revenue Next Year
- OCC N/A
- TPST N/A
- P/E Ratio
- OCC N/A
- TPST N/A
- Revenue Growth
- OCC 5.77
- TPST N/A
- 52 Week Low
- OCC $2.02
- TPST $5.35
- 52 Week High
- OCC $7.00
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- OCC 53.31
- TPST 72.61
- Support Level
- OCC $5.01
- TPST $6.96
- Resistance Level
- OCC $6.06
- TPST $10.90
- Average True Range (ATR)
- OCC 0.54
- TPST 0.63
- MACD
- OCC -0.09
- TPST 0.33
- Stochastic Oscillator
- OCC 57.34
- TPST 81.24
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.